A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance-Reference-Cited by-同舟云学术

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance

Published:1998-07 Issue:1 Volume:105 Page:7-11
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Revankar Sanjay G.,Kirkpatrick William R.,McAtee Robert K.,Dib Olga P.,Fothergill Annette W.,Redding Spencer W.,Rinaldi Michael G.,Hilsenbeck Susan G.,Patterson Thomas F.

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS;De Wit;Lancet,1989

2. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus;Koletar;Antimicrob Agents Chemo,1990

3. Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients;Just-Nubling;Eur J Clin Microbiol Infect Dis,1991

4. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia;Rex;Antimicrob Agents Chemo,1995

5. High prevalence of antifungal resistance in Candida spp. from patients with AIDS;Law;J Antimicrob Chem,1994

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of antifungal drugs for the treatment of oral candidiasis in HIV-positive patients: A Bayesian network meta-analysis;Medicina Clínica;2024-08

2. Comparative Efficacy and Safety of Antifungal Agents in the Prophylaxis of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis;Life;2022-03-31

3. A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17;Dermatology and Therapy;2022-02-15

4. Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents;Future Medicinal Chemistry;2019-04

5. Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people;Cochrane Database of Systematic Reviews;2018-08-29